A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT05020249 · COMPLETED
Trial details
- NCT number
- NCT05020249
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2022-09-05
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.